✦ LIBER ✦

Flutamide versus Stilboestrol in the Management of Advanced Prostatic Cancer: A Controlled Prospective Study

✍ Scribed by F. LUND; F. RASMUSSEN

Book ID: 115194390
Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 239 KB
Volume: 61
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1988.tb05062.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Randomised Study of Zoladex ve

Phase III Randomised Study of Zoladex versus Stilboestrol in the Treatment of Advanced Prostate Cancer

✍ B. WAYMONT; T. H. LYNCH; J. A. DUNN; L. A. EMTAGE; D. G. ARKELL; D. M. A. WALLAC 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ Paul Schellhammer; A. Lynn Patterson; Roohollah Sharifi; Michael Sarosdy; Norman 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 936 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ E. David Crawford 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

✍ M. Zerbib; C. Payan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 237 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer

✍ Gregory T. Bales; Gerald W. Chodak 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 611 KB

SELDI-TOF MS versus prostate specific an

SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case–control study of prostate cancer

✍ Åsa Skytt; Elin Thysell; Pär Stattin; Ulf-Håkan Stenman; Henrik Antti; Pernilla 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB

## Abstract There is an urgent need for better biomarkers for detection of clinically significant prostate cancer (PCa). Recent studies suggest that surface enhanced laser desorption/ionization time‐of‐flight mass spectrometry (SELDI‐TOF MS) analysis of serum may provide diagnostic information. The